• N/A
    Market Cap
  • 9,900.00%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
09/30/2021
Income Statement
Total Operating Revenue
239,962
N/A
Cost of Revenue
228,580
N/A
Gross Profit
11,382
N/A
Sales and Marketing Expense
N/A
N/A
Research and Development Expense
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
Total Operating Expenses
1.2M
N/A
Operating Profit
-1.2M
N/A
Interest Income
N/A
N/A
Interest Expense
-134,449
N/A
Interest Income and Expense and Net
-134,449
N/A
Total Nonoperating Income and Expense
-98,961
N/A
Income before Taxes
-1.2M
N/A
Income Taxes
N/A
N/A
Extraordinary Items
N/A
N/A
Net Income
-806,265
N/A
Net Income from Continuing Operations Applicable to Common
-806,265
N/A
Basic EPS and Net Income
-0.01
N/A
Diluted EPS and Net Income
-0.01
N/A
Basic Weighted Average Shares
120.9M
N/A
Diluted Weighted Average Shares
120.9M
N/A
Balance Sheet
Cash and Cash Equivalents
32,079
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
32,079
N/A
Total Current Assets
82,079
N/A
Accumulated Depreciation
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
Total Long-Term Assets
N/A
N/A
Total Assets
82,079
N/A
Income Taxes Payable
N/A
N/A
Total Short-Term Debt
2.1M
N/A
Total Current Liabilities
3.4M
N/A
Total Long-Term Debt
1.2M
N/A
Total Long-Term Liabilities
N/A
N/A
Total Liabilities
3.4M
N/A
Retained Earnings
-28.4M
N/A
Total Stockholders Equity
-3.0M
N/A
Total Shares Outstanding
123.9M
N/A
Cash Flow
Cash from Operating Activities
-925,191
N/A
Capital Expenditures
N/A
N/A
Cash from Investing Activities
N/A
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
905,950
N/A
Financials Ratio
Gross Margin
4.74%
N/A
Operating Margin
-511.69%
N/A
Return on Assets
-684.96%
N/A
Return on Equity
29.76%
N/A
Revenue Growth
4,699.24%
N/A
Current Ratio
0.02
N/A
Cash Ratio
0.009
N/A
Debt-to-Equity Ratio
-1.07
N/A
Debt-to-Assets Ratio
39.24
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow